To assess the impact of TAP2 loss on surface HLA-peptide complexes stabilization and tumor antigen-specific cancer cell killing, we performed peptide re-loading experiments by exposing parental or TAP2-deficient A549 cells to purified HER2369-377 or MAGE3271-279 peptides. This evidence concerns the gene LINC01194 and cancer.